Iron deposition lines in the cornea
FRCOphth/FRCS MCQs: Iron Lines in the Cornea – A Comprehensive Review
Watch the accompanying video here where I break down a high-yield FRCOphth Part 1 & 2 MCQ on corneal iron deposition lines. This topic frequently appears in written exams, testing your ability to differentiate benign epithelial phenomena from pathological corneal changes. As an FRCOphth candidate, mastering these distinctions sharpens clinical reasoning and slit-lamp interpretation skills.
In today's post, we dissect the MCQ step-by-step, explore pathophysiology, differential diagnoses, and exam-oriented frameworks.
Fleischer ring: Partial circumferential ring at the keratoconus cone base – linked to topographic pooling, not horizontal.
Stocker line: Vertical line nasal/superior to pterygium head.
Ferry line: Curved line peripheral to glaucoma filtration bleb.
Kayser-Fleischer ring: Copper deposition (Wilson’s disease) in Descemet’s membrane – symptomatic, systemic, slit-lamp golden ring at limbus.
In the video, I emphasize: always localize (position), morphology (line vs. ring), and associations (benign vs. pathological) for FRCOphth scoring.
Pathophysiology: Why Iron Deposits Form
Corneal iron lines represent ferritin-bound iron (not hemosiderin) granules in basal epithelial cells, visible as golden-brown pigmentation on slit-lamp (x16-25 magnification, narrow beam).
Key Mechanisms (Mnemonic: Tear Pooling, Basal Migration, Desiccation, Senescent cells – TPBDS):**
Tear Pooling Hypothesis: Iron in tears (0.1-1 mg/L) stagnates in interpalpebral areas due to lid-cornea dynamics, depositing via pH/ferritin binding. Hudson-Stähli forms at the "blink line" upper border.
Basal Cell Migration: Centripetal epithelial migration slows where cranial/caudal cells meet, accumulating extracellular iron.
Tear Desiccation: Evaporative loss concentrates iron in unstable tear film zones.
Senescent Basal Cells: Age-related reduced turnover traps iron.
Histology: Prussian blue stain confirms ferric iron (blue granules) in basal epithelium; no stromal involvement. Unlike siderosis bulbi (intracameral iron FB → toxic pupil/iris rust spots), these are superficial, non-toxic.
Differential Diagnosis: Framework for Vivas
Use Position – Shape – Associations – Symptoms grid for structured differentials (ideal for 10-min station):
| Line Type | Position | Shape/Length | Key Association | Symptoms/Pathology |
|---|---|---|---|---|
| Hudson-Stähli | Lower 1/3, horizontal | Straight, 1-2 mm | Normal aging (>50y), dry eye | Asymptomatic |
| Fleischer | Cone base (inferonasal) | Partial ring | Keratoconus | Progressive ectasia |
| Stocker | Superior/nasal to head | Vertical line | Pterygium (stable) | Surface irregularity |
| Ferry | Peripheral to bleb | Arcuate/golden | Post-glaucoma surgery | Bleb-related |
| Waring | Mid-periphery stellate | Stellate | Radial keratotomy | Post-refractive |
Key Differentiators: Hudson-Stähli lacks underlying pathology (vs. Fleischer's topography); not systemic overload (vs. KF ring – check LFTs, ceruloplasmin). Rare: Baum line (Salzmann nodules), post-graft lines.
Exam Tip: If image shown, state: "Golden-brown basal epithelial line, no stromal haze/Dalen-Fuchs – favors Hudson-Stähli over Fleischer (ectasia present)."
Clinical Associations
Benign Contexts: 13-80% post-refractive surgery (e.g., ICR-induced arcuate lines regress post-explant). Enhanced in HCQ toxicity (bull's-eye maculopathy co-check).
Red Flags: Unilateral? Trauma/FB history → B-scan for siderosis. Systemic? Fe studies normal (not hemochromatosis – rare limbal rust).
Investigations:
Slit-lamp: Confirm epithelial location (no anterior stromal haze).
Topography: Rule out ectasia.
Tear breakup (TBUT)/OSKI: Dry eye link.
No biopsy needed – benign.
UK Guidance: RCOphth Dry Eye (2022) notes lines as dry eye markers; monitor, not treat.
Management
Conservative – No Intervention: Asymptomatic, self-limiting (fades with age). Counsel: "Benign aging change, no vision impact".
If Symptomatic (rare irritation): Lubricants; lines regress with tear film stabilization.
Prognosis: Excellent – no progression, vision unaffected. Complications: None. Follow-up: PRN or annual if dry eye.
Old vs. New Strategies: Pre-2000s: Ignored. Now: Teledry eye scoring integrates lines as biomarkers.
